Skip to main content

Douglas T. Dieterich, MD

  • Specialty: Gastroenterology
  • Language: English

About Me

Conditions and Treatments

inflammatory bowel disease, gallbladder disease, liver diseases, flexible sigmoidoscopy, gastrointestinal disease, esophageal disorder, esophageal cancer, colonoscopy, human immunodeficiency virus, primary care

Credentials

Positions
  • Adjunct Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Gastroenterology), 1987
  • American Board of Internal Medicine - Internal Medicine, 1980
Education and Training
  • Fellowship, NYU Medical Center, Gastroenterology, 1983
  • Residency, NYU Medical Center, 1981
  • MD from New York University, 1978
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Research My Research

Research Summary

Spector, S., Weingeist, T., Pollard, R.B., et al. A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J. Infect. Dis. 1993; 168:557-560.

Dieterich D.T., Poles, M.A., Lew, E.A., et al. Concurrentl use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. J. Infect. Dis. 1993; 167: 1184-1188.

Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. 4. Visual Outcomes. Ophthalmology. 1994; 101: 1250-1261.

Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial-3. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch. Int. Med. 1995;155: 65-74.

Studies of Ocular complications of AIDS (SOCA) Research Group in collaboration with the AIDS Clinical Trials Group (ACTG). Foscarnet-GanciclovirCytomegalovirus Retinitis Trial-4. Visual outcomes. Ophthalmology.1994; 101: 1250-1261.

Department of Medicine Faculty Listing

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Publications

  • The Protective Effect of HCV Cure on HCC Risk May be over-Estimated in Patients with Advanced Liver Disease [Meeting Abstract]

    Branch, Andrea D.; Lewis, Sara; Wyatt, Brooke; Doyle, Erin; Sung, Julie C.; Misra, Suresh; Eng, Francis; Bosh, Ciara; Friedman, Scott L.; Dieterich, Douglas T.; Aloman, Costica; Branch-Elliman, Westyn; Perumalswami, Ponni V.

    Hepatology. 2018 OCT; 68:538A-539A

  • Early adoption of tenofovir alafenamide (TAF) for hepatitis B in us clinical practice; real-world evidence from the trio network [Meeting Abstract]

    Curry, M P; Bae, H; Dieterich, D T; Ankoma-Sey, V; Reddy, K R; Pan, C Q; Hann, H -W L; Tong, M J; Kim, W R; Kwo, P Y; Reau, N; Frazier, L; Milligan, S; Afdhal, N H

    Hepatology. 2018 October; Conference:(69th):252A

  • Treatment of hepatitis B in the us; real-world evidence from the trio network [Meeting Abstract]

    Bae, H; Curry, M P; Dieterich, D T; Ankoma-Sey, V; Reddy, K R; Pan, C Q; Hann, H -W L; Tong, M J; Kim, W R; Kwo, P Y; Reau, N; Frazier, L; Milligan, S; Afdhal, N H

    Hepatology. 2018 October; Conference:(69th):264A-265A

Read All Publications (270)

We can help you find a doctor. Call 646-929-7800 or
browse our specialists.